F. Stöckmann

4.0k total citations · 1 hit paper
79 papers, 2.7k citations indexed

About

F. Stöckmann is a scholar working on Surgery, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, F. Stöckmann has authored 79 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Surgery, 21 papers in Epidemiology and 16 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in F. Stöckmann's work include Neuroendocrine Tumor Research Advances (17 papers), Pancreatitis Pathology and Treatment (16 papers) and Diabetes Treatment and Management (10 papers). F. Stöckmann is often cited by papers focused on Neuroendocrine Tumor Research Advances (17 papers), Pancreatitis Pathology and Treatment (16 papers) and Diabetes Treatment and Management (10 papers). F. Stöckmann collaborates with scholars based in Germany, United States and Switzerland. F. Stöckmann's co-authors include W. Creutzfeldt, R. Ebert, Michael A. Nauck, J. Michael Conlon, P. G. Lankisch, G. Richter, R. Lamberts, G. Brunner, R. Nustede and Saskia M. Maas and has published in prestigious journals such as Gastroenterology, Diabetes and Gut.

In The Last Decade

F. Stöckmann

73 papers receiving 2.5k citations

Hit Papers

Reduced incretin effect i... 1986 2026 1999 2012 1986 250 500 750 1000

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
F. Stöckmann 1.4k 1.1k 728 583 580 79 2.7k
Håkan Ahlman 1.1k 0.8× 841 0.7× 1.7k 2.3× 2.1k 3.7× 572 1.0× 113 4.3k
Georgios Karanikas 445 0.3× 545 0.5× 376 0.5× 360 0.6× 235 0.4× 118 3.0k
Yuji Ishibashi 379 0.3× 785 0.7× 185 0.3× 162 0.3× 669 1.2× 107 2.2k
Jung Il Lee 472 0.3× 158 0.1× 236 0.3× 782 1.3× 421 0.7× 143 2.3k
Richard J. Comi 262 0.2× 357 0.3× 201 0.3× 329 0.6× 319 0.6× 42 1.3k
Toshiyuki Arai 1.3k 0.9× 64 0.1× 561 0.8× 289 0.5× 614 1.1× 139 3.0k
Christian Müller 676 0.5× 82 0.1× 452 0.6× 711 1.2× 328 0.6× 76 2.9k
Shuji Fukata 583 0.4× 1.9k 1.7× 235 0.3× 222 0.4× 465 0.8× 116 2.8k
A Wagner 624 0.4× 82 0.1× 566 0.8× 229 0.4× 442 0.8× 90 1.8k
Audrey S. Penn 897 0.6× 469 0.4× 115 0.2× 320 0.5× 989 1.7× 54 4.8k

Countries citing papers authored by F. Stöckmann

Since Specialization
Citations

This map shows the geographic impact of F. Stöckmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Stöckmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Stöckmann more than expected).

Fields of papers citing papers by F. Stöckmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Stöckmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Stöckmann. The network helps show where F. Stöckmann may publish in the future.

Co-authorship network of co-authors of F. Stöckmann

This figure shows the co-authorship network connecting the top 25 collaborators of F. Stöckmann. A scholar is included among the top collaborators of F. Stöckmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Stöckmann. F. Stöckmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stöckmann, F., et al.. (2009). The Effect of Cyclosporin A on Rat Pancreatic B-Cell: Interaction with the Calcium-Antagonist Diltiazem. Experimental and Clinical Endocrinology & Diabetes. 93(02/03). 213–218.
2.
Grunewald, R. Willi, et al.. (2008). Ungewöhnliche Diagnose bei rezidivierender Arthritis, Erythema nodosum und Herzrhythmusstörungen. DMW - Deutsche Medizinische Wochenschrift. 122(49). 1516–1520. 1 indexed citations
3.
Horstmann, O., R. Nustede, Wolfgang E. Schmidt, F. Stöckmann, & Heinz Becker. (1999). On the Role of Gastrin-Releasing Peptide in Meal-Stimulated Exocrine Pancreatic Secretion. Pancreas. 19(2). 126–132. 11 indexed citations
4.
Lehnick, Dirk, et al.. (1996). Etiology and Age Have Only a Limited Influence on the Course of Acute Pancreatitis. Pancreas. 13(4). 344–349. 54 indexed citations
5.
Nustede, R., et al.. (1994). Gastrin-releasing peptide and CCK after intraduodenal inhibition of proteases in dogs. International Journal of Pancreatology. 15(3). 209–214. 3 indexed citations
6.
Leonhardt, U., F. Seidensticker, F. Stöckmann, & W Creutzfeldt. (1993). Effect of Camostate Administration for Two Weeks on Experimental Pancreatitis in Mice and Rats. Pancreas. 8(1). 98–102. 9 indexed citations
7.
Leonhardt, U., et al.. (1992). Influence of a platelet-activating factor antagonist on severe pancreatitis in two experimental models. International Journal of Pancreatology. 12(2). 161–166. 22 indexed citations
8.
Leonhardt, U., et al.. (1991). Influence of the CCK-antagonist loxiglumide on bile-induced experimental pancreatitis. International Journal of Pancreatology. 10(1). 73–80. 5 indexed citations
9.
Creutzfeldt, W., et al.. (1991). Treatment of Gastrointestinal Endocrine Tumours with Interferon-α and Octreotide. Acta Oncologica. 30(4). 529–535. 45 indexed citations
10.
Leonhardt, U., et al.. (1990). Camostate (FOY-305) improves the therapeutic effect of peritoneal lavage on taurocholate induced pancreatitis.. Gut. 31(8). 934–937. 11 indexed citations
11.
Löser, Christian, et al.. (1989). Dose-dependent inhibition by cyclosporine a of the induction of pancreatic ornithine decarboxylase (ODC) in rats. International Journal of Pancreatology. 5(2). 179–189. 1 indexed citations
12.
Balks, H.J., J. Michael Conlon, W. Creutzfeldt, & F. Stöckmann. (1989). Effect of a long-acting somatostatin analogue (octreotide) on circulating tachykinins and the pentagastrin-induced carcinoid flush. European Journal of Clinical Pharmacology. 36(2). 133–137. 10 indexed citations
13.
Schmidt, Wolfgang E., F. Stöckmann, Anjona Roy Choudhury, et al.. (1989). Influence of CCK Antagonist L-364,718, Pancreastatin (33–49) and a Somatostatin Analogue on Camostate-induced Rat Pancreatic Hypertrophy. Digestion. 44(2). 105–116. 14 indexed citations
14.
Stöckmann, F., Hans-Christoph Fehmann, Burkhard Göke, E. G. Siegel, & W. Creutzfeldt. (1989). IMPAIRMENT OF STIMULATED INSULIN RELEASE FROM THE ISOLATED PERFUSED RAT PANCREAS BY CYCLOSPORINE PRETREATMENT. Transplantation. 48(3). 381–385. 9 indexed citations
15.
Fehmann, Hans-Christoph, et al.. (1988). Diltiazem inhibition of glucose-induced insulin secretion from the isolated perfused rat pancreas. European Journal of Pharmacology. 156(3). 415–417. 1 indexed citations
16.
Stöckmann, F., et al.. (1988). Approach to Hepatic Involvement by Endocrine Tumors of the Gastrointestinal Tract. Seminars in Liver Disease. 8(3). 254–262. 5 indexed citations
17.
Creutzfeldt, W., et al.. (1986). Effect of Short- and Long-Term Feeding of Omeprazole on Rat Gastric Endocrine Cells. Digestion. 35(1). 84–97. 71 indexed citations
18.
Göke, Burkhard, F. Stöckmann, R. Müller, P. G. Lankisch, & W. Creutzfeldt. (1984). Effect of a Specific Serine Protease Inhibitor on the Rat Pancreas: Systemic Administration of Camostate and Exocrine Pancreatic Secretion. Digestion. 30(3). 171–178. 40 indexed citations
19.
Stöckmann, F.. (1976). Das geistig behinderte Kind im Heim.
20.
Stöckmann, F.. (1961). Optoelektronik. Physikalische Blätter. 17(1). 14–20. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026